189 related articles for article (PubMed ID: 34249445)
1. G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer.
Oshi M; Patel A; Le L; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
Am J Cancer Res; 2021; 11(6):3070-3084. PubMed ID: 34249445
[TBL] [Abstract][Full Text] [Related]
2. High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection.
Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Katz MHG; Takabe K
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33036243
[TBL] [Abstract][Full Text] [Related]
3. A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer.
Oshi M; Tokumaru Y; Patel A; Yan L; Matsuyama R; Endo I; Katz MHG; Takabe K
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291601
[TBL] [Abstract][Full Text] [Related]
4. Accelerated glycolysis in tumor microenvironment is associated with worse survival in triple-negative but not consistently with ER+/HER2- breast cancer.
Oshi M; Roy AM; Yan L; Sasamoto M; Tokumaru Y; Wu R; Yamada A; Yamamoto S; Chishima T; Narui K; Endo I; Takabe K
Am J Cancer Res; 2023; 13(7):3041-3054. PubMed ID: 37559984
[TBL] [Abstract][Full Text] [Related]
5. G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer.
Oshi M; Takahashi H; Tokumaru Y; Yan L; Rashid OM; Matsuyama R; Endo I; Takabe K
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331421
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer with enhanced myogenesis is associated with less cell proliferation, enriched epithelial-to-mesenchymal transition and angiogenesis, and poor clinical outcomes.
Chida K; Oshi M; An N; Kanazawa H; Roy AM; Mann GK; Yan L; Endo I; Hakamada K; Takabe K
Am J Cancer Res; 2024; 14(1):355-367. PubMed ID: 38323295
[TBL] [Abstract][Full Text] [Related]
7. High Ki67 Gene Expression Is Associated With Aggressive Phenotype in Hepatocellular Carcinoma.
Ramos-Santillan V; Oshi M; Nelson E; Endo I; Takabe K
World J Oncol; 2024 Apr; 15(2):257-267. PubMed ID: 38545476
[TBL] [Abstract][Full Text] [Related]
8. A novel five-gene score to predict complete pathological response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer.
Oshi M; Gandhi S; Angarita FA; Kim TH; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
Am J Cancer Res; 2021; 11(7):3611-3627. PubMed ID: 34354863
[TBL] [Abstract][Full Text] [Related]
9. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
[TBL] [Abstract][Full Text] [Related]
10. Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer.
Oshi M; Gandhi S; Yan L; Tokumaru Y; Wu R; Yamada A; Matsuyama R; Endo I; Takabe K
Breast Cancer Res Treat; 2022 Jul; 194(2):231-241. PubMed ID: 35639264
[TBL] [Abstract][Full Text] [Related]
11. High
Nelson ED; Benesch MG; Wu R; Ishikawa T; Takabe K
Am J Cancer Res; 2024; 14(1):227-242. PubMed ID: 38323277
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral lymphatic endothelial cell infiltration reflecting lymphangiogenesis is counterbalanced by immune responses and better cancer biology in the breast cancer tumor microenvironment.
Wu R; Sarkar J; Tokumaru Y; Takabe Y; Oshi M; Asaoka M; Yan L; Ishikawa T; Takabe K
Am J Cancer Res; 2022; 12(2):504-520. PubMed ID: 35261783
[TBL] [Abstract][Full Text] [Related]
13. The dual role of the DREAM/G2M pathway in non-tumorigenic immortalization of senescent cells.
Tian J; Jiang L; Li H; Dan J; Luo Y
FEBS Open Bio; 2024 Feb; 14(2):331-343. PubMed ID: 38073074
[TBL] [Abstract][Full Text] [Related]
14. The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2- Breast Cancer.
Oshi M; Takahashi H; Tokumaru Y; Yan L; Rashid OM; Nagahashi M; Matsuyama R; Endo I; Takabe K
Cells; 2020 Jul; 9(7):. PubMed ID: 32650578
[TBL] [Abstract][Full Text] [Related]
15. A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Oshi M; Angarita FA; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065619
[TBL] [Abstract][Full Text] [Related]
16. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
[TBL] [Abstract][Full Text] [Related]
17. Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
Yang D; Ma Y; Zhao P; Ma J; He C
Biomed Pharmacother; 2019 Dec; 120():109433. PubMed ID: 31568988
[TBL] [Abstract][Full Text] [Related]
18. E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma.
Chida K; Oshi M; Roy AM; Yachi T; Nara M; Yamada K; Matsuura O; Hashizume T; Endo I; Takabe K
Surgery; 2023 Aug; 174(2):307-314. PubMed ID: 37198038
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment.
Gandhi S; Oshi M; Murthy V; Repasky EA; Takabe K
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071012
[TBL] [Abstract][Full Text] [Related]
20. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
